Why the markets see trouble ahead for the US.
Good morning! Pharma execs are sweating bullets this week as Trump’s latest drug pricing proposal threatens to drain a staggering $1 trillion from their pockets.
Today, we're diving into UPS’s plan to cut 20,000 jobs — and how European banks are the unlikely beneficiaries of Trump’s trade policies.
We're diving into Tesla's latest financial woes and the political turbulence causing headaches for Elon Musk
